HRPC(SH:600829) Xin Lang Cai Jing·2025-08-09 01:43Core Points - Company reported a total revenue of 5.149 billion yuan, an increase of 164 million yuan or 3.29% year-on-year [1] - Net profit attributable to shareholders decreased to 72.5792 million yuan, down 6.26126 million yuan or 46.31% year-on-year [1] - Operating cash flow showed a net outflow of 127 million yuan, an increase in inflow of 78.6296 million yuan compared to the same period last year [1] Financial Ratios - The latest debt-to-asset ratio is 57.87%, a decrease of 1.47 percentage points from the previous quarter and a decrease of 3.14 percentage points year-on-year [3] - The latest gross profit margin is 8.04%, an increase of 0.22 percentage points from the previous quarter but a decrease of 1.04 percentage points year-on-year [3] - Return on equity (ROE) stands at 2.46%, down 2.37 percentage points compared to the same period last year [3] Earnings and Turnover - Diluted earnings per share are 0.13 yuan, a decrease of 0.11 yuan or 46.29% year-on-year [4] - Total asset turnover ratio is 0.73 times, an increase of 0.04 times or 6.49% year-on-year [4] - Inventory turnover ratio is 4.35 times, an increase of 0.21 times or 5.06% year-on-year [4] Shareholding Structure - The number of shareholders is 27,700, with the top ten shareholders holding 442 million shares, accounting for 76.25% of the total share capital [4] - The largest shareholder is Harbin Pharmaceutical Group Co., Ltd., holding 74.82% [4]